TNDM

Tandem Diabetes Care, Inc.

TNDM · CIK 1438133 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$290M
20182025
Net Income−$1M
20182025
Operating CF−$10M
20182025
Free Cash Flow−$30M
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$0.3B$0.3B$0.2B$0.2B$0.2B$0.2B$0.1B$0.1B
Cost of Revenue$0.5B$0.5B$0.4B$0.4B$0.3B$0.2B$0.2B$0.1B
Gross Profit$0.2B$0.2B$0.1B$0.1B$0.1B$0.1B$0.1B$0.0B
R&D Expense————$0.1B$0.1B$0.0B$0.0B
SG&A Expense$0.4B$0.4B$0.4B$0.3B$0.3B$0.2B$0.2B$0.1B
Operating Income$0.0B$-0.0B$-0.0B$-0.0B$0.0B$0.0B$0.0B$0.0B
Net Income$-0.0B$0.0B$-0.0B$-0.0B$0.0B$-0.0B$0.0B$0.0B
EPS (Basic)$-0.01$0.01$-0.46$-0.25$0.17$0.27$0.04$0.06
EPS (Diluted)$-0.01$0.01$-0.46$-0.25$0.16$0.22$0.04$0.02

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$0.9B$1.0B$1.0B$1.1B$0.9B$0.7B$0.3B$0.2B
Current Assets$0.6B$0.7B$0.7B$0.8B$0.8B$0.6B$0.3B$0.2B
Cash & Equivalents$0.1B$0.1B$0.1B$0.2B$0.1B$0.1B$0.1B$0.0B
Total Liabilities$0.7B$0.7B$0.6B$0.6B$0.5B$0.4B$0.1B$0.1B
Current Liabilities$0.2B$0.2B$0.2B$0.2B$0.1B$0.1B$0.1B$0.1B
Stockholders' Equity$0.2B$0.3B$0.3B$0.4B$0.4B$0.4B$0.2B$0.1B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$-0.0B$0.0B$-0.0B$0.1B$0.1B$0.0B$0.0B$-0.0B
Investing Cash Flow$0.1B$-0.0B$-0.1B$0.0B$-0.2B$-0.3B$-0.1B$-0.1B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$-0.0B$0.0B$0.0B$0.0B$0.1B$0.3B$0.0B$0.1B
← Companies